Virios Therapeutics Stock Forecast for 2023 - 2025 - 2030

Updated on 05/18/2024

Stock Rating
0
Price Target
$2.20
Consensus
Neutral
Upside
528.57%
Analysts
1
Stock Rating
0
Upside
528.57%
Analysts
1
Price Target
$2.20

Virios Therapeutics Stock Forecast and Price Target

The average price target for Virios Therapeutics's stock set by recognized analysts recently is $2.20, which would result in a potential upside of approximately 528.57% if it reached this mark. The estimation is based on a high estimate of $4.00 and a low estimate of $0.40.

$2.20

528.57% Upside

Hold
Hold

Virios Therapeutics Fair Value Forecast for 2023 - 2025 - 2030

In the last three years, Virios Therapeutics's Price has grown, increasing from $0.00 to $0.00 – an increase of 100.00%. For next year, the 0 analysts predict Fair Value of $0.00, which would mean an increase of 100.00%. Over the next six years, the pros' prediction is Fair Valueof $0.00, which would mean a six-year growth forecast of 100.00%.

2025 Fair Value Forecast
$0.00
2026 Fair Value Forecast
$0.00
2027 Fair Value Forecast
$0.00
2028 Fair Value Forecast
$0.00
2029 Fair Value Forecast
$0.00
2030 Fair Value Forecast
$0.00

Virios Therapeutics Revenue Forecast for 2023 - 2025 - 2030

Virios Therapeutics Dividend per Share Forecast for 2023 - 2025 - 2030

Virios Therapeutics Free Cash Flow Forecast for 2023 - 2025 - 2030

Virios Therapeutics EBITDA Forecast for 2023 - 2025 - 2030

Virios Therapeutics EBIT Forecast for 2023 - 2025 - 2030

In the last three years, Virios Therapeutics has seen a decline in its EBIT, from $-10.01M to $-5.45M – a 45.55% decrease. Next year, analysts are expecting EBIT to reach $-7.58M – an increase of 39.00%. Over the next seven years, the forecast is for EBIT to grow by 103.70%.

2024 EBIT Forecast
$-7575681.67
2025 EBIT Forecast
$-10730953.08
2026 EBIT Forecast
$-13184764.35
2027 EBIT Forecast
$-9841547.60
2028 EBIT Forecast
$-9380963.18
2029 EBIT Forecast
$-10014803.59
2030 EBIT Forecast
$-11101409.78

Virios Therapeutics EPS Price Prediction Forecast for 2023 - 2025 - 2030

In the last three years, Virios Therapeutics's EPS has grown, increasing from $-1.92 to $0.00 – an increase of 100.00%. For next year, the 0 analysts predict EPS of $0.00, which would mean an increase of 100.00%. Over the next six years, the pros' prediction is EPSof $0.00, which would mean a six-year growth forecast of 100.00%.

2025 EPS Forecast
$0.00
2026 EPS Forecast
$0.00
2027 EPS Forecast
$0.00
2028 EPS Forecast
$0.00
2029 EPS Forecast
$0.00
2030 EPS Forecast
$0.00